Company intelligence / Profile preview

Shenzen CAS Health

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Shenzhen CAS-Envision Medical Technology Co., Ltd. is a high-tech startup founded in 2018, originating from artificial retina R&D at the Chinese Academy of Sciences (CAS). The company focuses on chip-level medical treatment, developing and manufacturing medical devices, diagnostics (molecular and rapid tests), and epidemic prevention products. It is an active trading company with GMP-certified manufacturing capabilities, backed by SIAT/CAS and local governments.

Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Shenzen CAS Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzen CAS Health.

Explore the full profile